Advancing Biopharma R&D, Business Analytics, and Decision Making
Portfolio prioritization, agile capacity management and resource allocation, risk mitigation, and overall strategic decision making are becoming increasing difficult in today’s ever-changing pharma R&D landscape. Cambridge Healthtech
Institute’s Biopharma Strategy Series presents Executive Decision Making 2022, 3 days of high-level content, interactive discussions and networking, breakout roundtables, 1:1 meetings, and much more! Attendees will leave with
new tools and organizational strategies to improve strategic decision making, optimize portfolio prioritization and resource planning, and drive value and resilience.